5 Healthcare Stocks to Buy According to Billionaire DE Shaw

3. Amgen Inc. (NASDAQ:AMGN)

D E Shaw Stake Value: $267,103,000
Percentage of D E Shaw’s 13F Portfolio: 0.24%
Number of Hedge Fund Holders: 52

Amgen Inc. (NASDAQ:AMGN) is an American global biopharmaceutical corporation. Amgen Inc. (NASDAQ:AMGN) declared a quarterly dividend of $1.94 per share on December 3, up 10.2% from the previous payout of $1.76.

On December 6, Salveen Richter of Goldman Sachs initiated coverage of Amgen Inc. (NASDAQ:AMGN), rating the stock as “Buy” rating and gave a price target of $258.

As of the end of the third quarter of 2021, 52 hedge funds in Insider Monkey’s database held stakes in Amgen Inc. (NASDAQ:AMGN), compared to 53 funds in the earlier quarter.

Two Sigma Advisors, with 1.85 million shares, is the most significant stakeholder in Amgen Inc. (NASDAQ:AMGN).

In its third-quarter 2021 investor letter, Smead Capital Management mentioned Amgen Inc. (NASDAQ:AMGN). Here is what the fund said:

“Our poor performers for the quarter were quite eclectic. Amgen (AMGN) suffered a 12% decline from the Delta variant of COVID-19 retarding doctor visits and reducing new prescriptions.”